AMRI has acquired Hyaluron Inc., expanding AMRI’s contract manufacturing capabilities to include cGMP manufacturing and sterile filling of parenteral drugs to the biopharmaceutical industry. AMRI has acquired all facilities, equipment and staff at a purchase price, including debt, of approximately $27 million. Hyaluron is a contract manufacturer in the sterile syringe and vial filling areas, providing services for both small molecule drug products and biologicals, from clinical phase to comme...